Skip to Data Use Notice
Skip to main content
Site Logo
Search site
Search
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
Section
P&T Committee Information
August 20, 2026
Related files
Tentative agenda
Draft PDL - August 20, 2026
Reports
There are no files currently available.
Drug mongraphs
Baxfendy
Byqlovi
Bysanti
Cardamyst
Ensacove
Forzinity
Icotyde
Idvynso
Komzifti
Kygevvi
Lifyorli
Myqorzo
Nereus
Pivya
Redemplo
Saphnelo
Yuviwel
Drug class reviews
There are no files currently available.
Archive
There are no files currently available.
back to top
back to top
